MDxHealth (MDXH) Liabilities and Shareholders Equity (2020 - 2026)

MDxHealth has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $160.8 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 8.01% year-over-year to $160.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $463.2 million (down 25.34% YoY) and the FY2025 annual result came in at $148.0 million, down 5.96% from the prior year.
• Liabilities and Shareholders Equity improved to $160.8 million in Q1 2026 per MDXH's latest filing, from $148.0 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $174.8 million in Q1 2025 and troughed at $162501.0 in Q2 2025.
• A 5-year average of $133.3 million and a median of $139.1 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity surged 58.69% in 2022, then plunged 99.88% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $119.1 million in 2022, then advanced by 8.39% to $129.1 million in 2023, then rose by 21.84% to $157.3 million in 2024, then fell by 5.96% to $148.0 million in 2025, then increased by 8.7% to $160.8 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $160.8 million, $148.0 million, and $154.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.